New Delhi: The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, is organising the 9th edition of India Pharma 2026. The event is being held in association with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA) on April 13-14, 2026, at Federation House, FICCI, New Delhi.
The event will be inaugurated by Jagat Prakash Nadda, Union Minister of Chemicals & Fertilizers, and Anupriya Patel, Union Minister of State for Chemicals & Fertilizers. The conference serves as a platform for sectoral growth and international collaboration, focusing on India’s pharmaceutical capabilities, research and development (R&D), and the resilience of global supply chains.
The theme for this year’s edition is “Discover in India: Leapfrogging Life-Sciences Innovation.” Aligned with India’s vision of emerging as a global pharma innovation hub, the theme highlights the transformative potential of life sciences in enhancing healthcare access, driving economic growth, and strengthening global health systems. India continues to play a pivotal role in the global supply of affordable, high-quality medicines. Building on this strong foundation, India Pharma 2026 aims to accelerate the sector’s transition from a volume-driven model to a value- and innovation-led global powerhouse.
The two-day event will witness the participation of a distinguished lineup of policymakers, industry leaders, and domain experts from across the pharmaceutical sector. Prominent dignitaries include Manoj Joshi, Secretary, Department of Pharmaceuticals; Punya Salila Srivastava, Secretary, Ministry of Health & Family Welfare; and Prof. Vinod K. Paul, Member, NITI Aayog. The event will also feature eminent domain experts such as Dr. Renu Swarup, Former Secretary, Department of Biotechnology; and Dr. Shivkumar Kalyanaraman, CEO, Anusandhan National Research Foundation.
The regulatory perspective will be represented by Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India (DCGI), along with Dr. A. Visala, Joint Drugs Controller (India), CDSCO, and Gregory Smith, Country Director (India), US FDA, bringing both domestic and global regulatory insights. The industry will be represented by leading industrialists such as Dilip Shanghvi of Sun Pharma and Pankaj Patel of Zydus Lifesciences, along with FICCI Pharma Committee leadership including Arjun Juneja, COO, Mankind Pharma Ltd.; Achin Gupta, Managing Director & Global CEO, Cipla Ltd.; Winselow Tucker, President and General Manager, Eli Lilly & Company (India); and Kartik Rajendran, Managing Director, Abbott India.
Apart from a dedicated special session, Start-up Showcase, the two- day event will feature following six plenary sessions:
- Policy Thrust for Catalysing Innovation
- Enabling Regulatory Ecosystem to Foster Innovation
- Harnessing AI and Next-Gen Technologies for Disruptive Innovation
- Unleashing India’s CRDMO Potential
- Developing a Vibrant Pharma Financing Ecosystem
- Reflections and Big Moves to Leapfrog Innovation
The Federation of Indian Chambers of Commerce and Industry (FICCI), established in 1927, is India’s oldest and largest apex business organization. A non-government, not-for-profit body, FICCI represents the voice of India’s business and industry, serving a diverse membership of over 2,50,000 companies, including corporate entities and multinational firms, through its extensive network of regional chambers across the country.
The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers is supporting the country’s pharmaceutical and medtech sector to drive innovation and Atma Nirbharta, with focused policy interventions, infrastructure development & strengthened industry-academia partnerships, aligned with the broader vision of Viksit Bharat 2047.
